AAAAAA
Results: 1-25/1750
Authors:
Abramson, SB
Citation: Sb. Abramson, Controversies in COX-2 inhibitor therapy - Introduction, CLIN EXP RH, 19(6), 2001, pp. S1-S2
Authors:
Moskowitz, RW
Citation: Rw. Moskowitz, The role of anti-inflammatory drugs in the treatment of osteoarthritis: a United States viewpoint, CLIN EXP RH, 19(6), 2001, pp. S3-S8
Authors:
Dougados, M
Citation: M. Dougados, The role of anti-inflammatory drugs in the treatment of osteoarthritis: a European viewpoint, CLIN EXP RH, 19(6), 2001, pp. S9-S14
Authors:
Hochberg, MC
Citation: Mc. Hochberg, What have we learned from the large outcomes trials of COX-2 selective inhibitors? The rheumatologist's perspective, CLIN EXP RH, 19(6), 2001, pp. S15-S22
Authors:
Hawkey, CJ
Citation: Cj. Hawkey, NSAIDs and COX-2 inhibitors: what can we learn from large outcomes trials?The gastroenterologist's perspective, CLIN EXP RH, 19(6), 2001, pp. S23-S30
Authors:
FitzGerald, GA
Cheng, Y
Austin, S
Citation: Ga. Fitzgerald et al., COX-2 inhibitors and the cardiovascular system, CLIN EXP RH, 19(6), 2001, pp. S31-S36
Authors:
Appel, GB
Citation: Gb. Appel, COX-2 inhibitors and the kidney, CLIN EXP RH, 19(6), 2001, pp. S37-S40
Authors:
Rodriguez, LAG
Citation: Lag. Rodriguez, The effect of NSAIDs on the risk of coronary heart disease: fusion of clinical pharmacology and pharmacoepidemiologic data, CLIN EXP RH, 19(6), 2001, pp. S41-S44
Authors:
Patrono, C
Citation: C. Patrono, Measurement of cyclooxygenase isozyme inhibition in humans: exploring the clinical relevance of biochemical selectivity, CLIN EXP RH, 19(6), 2001, pp. S45-S50
Authors:
Brune, K
Neubert, A
Citation: K. Brune et A. Neubert, Pharmacokinetic and pharmacodynamic aspects of the ideal COX-2 inhibitor: a pharmacologist's perspective, CLIN EXP RH, 19(6), 2001, pp. S51-S57
Authors:
Day, RO
Citation: Ro. Day, Pharmacokinetic and pharmacodynamic aspects of the ideal COX-2 inhibitor: a rheumatologist's perspective, CLIN EXP RH, 19(6), 2001, pp. S59-S62
Authors:
Dionne, RA
Khan, AA
Gordon, SM
Citation: Ra. Dionne et al., Analgesia and COX-2 inhibition, CLIN EXP RH, 19(6), 2001, pp. S63-S70
Authors:
Furst, DE
Manning, DC
Citation: De. Furst et Dc. Manning, Future directions in pain management, CLIN EXP RH, 19(6), 2001, pp. S71-S76
Authors:
Abramson, SB
Furst, DE
Hochberg, MC
Patrono, C
Citation: Sb. Abramson et al., Controversies in COX-2 inhibitor therapy: Closing remarks, CLIN EXP RH, 19(6), 2001, pp. S77-S80
Authors:
Ben-Chetrit, E
Levy, M
Citation: E. Ben-chetrit et M. Levy, Enigmas in familial Mediterranean fever (FMF), CLIN EXP RH, 19(5), 2001, pp. S1-S5
Authors:
Gul, A
Citation: A. Gul, Behcet's disease: An update on the pathogenesis, CLIN EXP RH, 19(5), 2001, pp. S6-S12
Authors:
Aral, O
Ozdogan, H
Yazici, H
Citation: O. Aral et al., The other physician behind the use of colchicine for the treatment of familial Mediterranean fever, CLIN EXP RH, 19(5), 2001, pp. S13-S14
Authors:
Eksioglu-Demiralp, E
Direskeneli, H
Kibaroglu, A
Yavuz, S
Ergun, T
Akoglu, T
Citation: E. Eksioglu-demiralp et al., Neutrophil activation in Behcet's disease, CLIN EXP RH, 19(5), 2001, pp. S19-S24
Authors:
Kiraz, S
Ertenli, I
Calguneri, M
Ozturk, MA
Haznedaroglu, IC
Altun, B
Erman, M
Celik, I
Citation: S. Kiraz et al., Interactions of nitric oxide and superoxide dismutase in Behcet's disease, CLIN EXP RH, 19(5), 2001, pp. S25-S29
Authors:
Chang, HK
Kim, JU
Cheon, KS
Chung, HR
Lee, KW
Lee, IH
Citation: Hk. Chang et al., HLA-B51 and its allelic types in association with Behcet's disease and recurrent aphthous stomatitis in Korea, CLIN EXP RH, 19(5), 2001, pp. S31-S35
Authors:
Ertenli, I
Kiraz, S
Calguneri, M
Celik, I
Erman, M
Haznedaroglu, IC
Kirazli, S
Citation: I. Ertenli et al., Synovial fluid cytokine levels in Behcet's disease, CLIN EXP RH, 19(5), 2001, pp. S37-S41
Authors:
Dinc, A
Melikoglu, M
Korkmaz, C
Fresko, I
Ozdogan, H
Yazici, H
Citation: A. Dinc et al., Nailfold capillary abnormalities in patients with familial Mediterranean fever, CLIN EXP RH, 19(5), 2001, pp. S42-S44
Authors:
Tunc, R
Uluhan, A
Melikoglu, M
Ozyazgan, Y
Ozdogan, H
Yazici, H
Citation: R. Tunc et al., A reassessment of the International Study Group criteria for the diagnosis(classification) of Behcet's syndrome, CLIN EXP RH, 19(5), 2001, pp. S45-S47
Authors:
Houman, MH
Ben Ghorbel, I
Ben Salah, IK
Lamloum, M
Ben Ahmed, M
Miled, M
Citation: Mh. Houman et al., Deep vein thrombosis in Behcet's disease, CLIN EXP RH, 19(5), 2001, pp. S48-S50
Authors:
Chang, HK
Choi, YJ
Baek, SK
Lee, DH
Won, KS
Citation: Hk. Chang et al., Osteonecrosis and bone infarction in association with Behcet's disease: Report of two cases, CLIN EXP RH, 19(5), 2001, pp. S51-S54